checkAd
    Startseite > Aktien > Seres Therapeutics > Nachrichten
    Seres Therapeutics Aktie
    0,9217
     
    USD
    -0,84 %
    -0,0078 USD
    Letzter Kurs 02:00:00 NMS
    0,9264
     
    USD
    4.000 STK
    Geldkurs 29.05.24
    0,9283
     
    USD
    1.300 STK
    Briefkurs 29.05.24
    ISIN: US81750R1023 · WKN: A14VXX · SYM: MCRB · USA

    Neueste Nachrichten

    Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
    08.05.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    06.05.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024
    06.05.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
    09.04.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    28.03.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    19.03.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
    28.02.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
    27.02.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
    26.02.24 · Business Wire (engl.) · Seres Therapeutics
    Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    17.01.24 · Business Wire (engl.) · Seres Therapeutics
    Fokus Aktien mit extremen Handelsvolumen am Dienstag, den 09.01.2024
    09.01.24 · wO Chartvergleich · Diana Shipping
    Seres Therapeutics Announces VOWST Commercial Launch Update and US FDA Fast Track Designation for SER-155
    09.01.24 · Business Wire (engl.) · Seres Therapeutics